Correlated expression of peroxisome proliferator-activated receptor γ with high histologic grade and basal type in invasive ductal carcinoma of the breast
Hoiseon Jeong, Youngseok Lee, Jungsuk An, Ok Hee Woo, KyongHwa Park, Aeree Kim
{"title":"Correlated expression of peroxisome proliferator-activated receptor γ with high histologic grade and basal type in invasive ductal carcinoma of the breast","authors":"Hoiseon Jeong, Youngseok Lee, Jungsuk An, Ok Hee Woo, KyongHwa Park, Aeree Kim","doi":"10.1111/j.1755-9294.2009.01053.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p> <b>Backgroud and aim:</b> Peroxisome proliferator-activated receptor γ (PPARγ) is one of the ligand-activated transcription factors belonging to the nuclear hormone receptor family. The protein is expressed in various kinds of tumor and has been implicated as a tumor suppressor in most cancers. We aimed to understand the role of PPARγ in breast cancer. <b>Methods:</b> The expression of PPARγ in 288 cases of invasive ductal carcinoma was examined using tissue microarray and immunohistochemistry. <b>Results:</b> PPARγ immunoreactivity was detected in 21.5% of cases and significantly associated with expression of EGFR and ki-67 (<i>P</i>= 0.008; <i>P</i>= 0.046). PPARγ expression was correlated with high histological grade and basal type (<i>P</i>≤ 0.001; <i>P</i>= 0.009). <b>Conclusions:</b> PPARγ expression is related to poor prognostic factors of breast cancer. It is considered that PPARγ has evident tumor promoting properties <i>in vivo</i>, but receptor-independent effects of PPARγ ligands may compound its biologic effects in cancer. A better understanding of action mechanisms of the activated PPARγ is required.</p>\n </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 4","pages":"118-124"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01053.x","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic and applied pathology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1755-9294.2009.01053.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Backgroud and aim: Peroxisome proliferator-activated receptor γ (PPARγ) is one of the ligand-activated transcription factors belonging to the nuclear hormone receptor family. The protein is expressed in various kinds of tumor and has been implicated as a tumor suppressor in most cancers. We aimed to understand the role of PPARγ in breast cancer. Methods: The expression of PPARγ in 288 cases of invasive ductal carcinoma was examined using tissue microarray and immunohistochemistry. Results: PPARγ immunoreactivity was detected in 21.5% of cases and significantly associated with expression of EGFR and ki-67 (P= 0.008; P= 0.046). PPARγ expression was correlated with high histological grade and basal type (P≤ 0.001; P= 0.009). Conclusions: PPARγ expression is related to poor prognostic factors of breast cancer. It is considered that PPARγ has evident tumor promoting properties in vivo, but receptor-independent effects of PPARγ ligands may compound its biologic effects in cancer. A better understanding of action mechanisms of the activated PPARγ is required.